Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase by Kronenberg, G. et al.
Neurobiology of Disease
Folate Deficiency Induces Neurodegeneration and Brain
Dysfunction in Mice Lacking Uracil DNA Glycosylase
Golo Kronenberg,1,2,4* Christoph Harms,1* Robert W. Sobol,5,6,7 Fernando Cardozo-Pelaez,8Heinz Linhart,9
BenjaminWinter,1Mustafa Balkaya,1 Karen Gertz,1 Shanna B. Gay,6David Cox,8 Sarah Eckart,4Michael Ahmadi,1
Georg Juckel,10 Gerd Kempermann,1,11 Rainer Hellweg,4 Reinhard Sohr,3Heide Ho¨rtnagl,3 Samuel H. Wilson,7
Rudolf Jaenisch,9 andMatthias Endres1,2
1Klinik und Poliklinik fu¨r Neurologie, 2Center for Stroke Research Berlin, and 3Institut fu¨r Pharmakologie und Toxikologie, Charite´-Universita¨tsmedizin
Berlin, Campus Mitte, D-10117 Berlin, Germany, 4Klinik und Hochschulambulanz fu¨r Psychiatrie und Psychotherapie, Charite´-Universita¨tsmedizin Berlin,
Campus Benjamin Franklin, 14050 Berlin, Germany, 5Department of Pharmacology, University of Pittsburgh School of Medicine and 6University of
Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania 15213-1863, 7Laboratory of Structural Biology, National Institute of
Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 277096, 8Department of Biomedical and
Pharmaceutical Sciences, Center for Environmental Health Sciences, University of Montana, Missoula, Montana 59812, 9Whitehead Institute,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, 10Westfa¨lisches Zentrum, Ruhr-Universita¨t Bochum, D-44791 Bochum,
Germany, and 11Max Delbru¨ck Center for Molecular Medicine, D-13125 Berlin-Buch, Germany
Folate deficiency and resultant increased homocysteine levels have been linked experimentally and epidemiologically with neurodegen-
erative conditions like stroke anddementia.Moreover, folate deficiency has been implicated in the pathogenesis of psychiatric disorders,
most notably depression.Wehypothesized that the pathogenicmechanisms includeuracilmisincorporation and, therefore, analyzed the
effects of folate deficiency in mice lacking uracil DNA glycosylase (Ung/) versus wild-type controls. Folate depletion increased
nuclear mutation rates in Ung/ embryonic fibroblasts, and conferred death of cultured Ung/ hippocampal neurons. Feeding
animals a folate-deficient diet (FD) for 3 months induced degeneration of CA3 pyramidal neurons in Ung/ but not Ung/mice
along with decreased hippocampal expression of brain-derived neurotrophic factor protein and decreased brain levels of antioxidant
glutathione. Furthermore, FD induced cognitive deficits and mood alterations such as anxious and despair-like behaviors that were
aggravated in Ung/mice. Independent of Ung genotype, FD increased plasma homocysteine levels, altered brain monoamine me-
tabolism, and inhibited adult hippocampal neurogenesis. These results indicate that impaired uracil repair is involved in neurodegen-
eration and neuropsychiatric dysfunction induced by experimental folate deficiency.
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Introduction
Folate deficiency is associated with elevated levels of homocys-
teine, cerebrovascular and neurological diseases, and mood dis-
orders (D’Anci and Rosenberg, 2004). The importance of folate
in the nervous system was initially demonstrated in studies that
established a greatly increased risk of neurodevelopmental disor-
ders in the offspring of folate-deficient pregnant women (Smith-
ells et al., 1976; Laurence et al., 1981; Blom et al., 2006). In the
adult, epidemiological studies have linked lack of folate to neu-
rodegenerative and neuropsychiatric diseases, including stroke,
Parkinson’s disease, dementia, and depression (Reynolds, 2002;
He et al., 2004; Irizarry et al., 2005; Lamberti et al., 2005). In 1962,
VictorHerbert reported insomnia, irritability, fatigue, andmem-
ory impairment as prominent symptoms of his self-inflicted fo-
late deficiency, all of which were amenable to folate supplemen-
tation (Herbert, 1962).
The mechanisms by which chronic folate deficiency adversely
affects CNS function are incompletely understood. Folic acid
plays an essential role in one-carbon metabolism: it is required
both in the remethylation of homocysteine to methionine and in
the synthesis of S-adenosyl-methionine, the principal biological
methyl donor in numerousmethylation reactions. ReducedDNA
methylation during folate deficiency results in altered gene ex-
pression and thereby may disrupt genome integrity (Bergman
and Mostoslavsky, 1998). Dietary folate also has a major impact
on homocysteine levels, which may exert direct neurotoxic and
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pro-oxidative actions (Lipton et al., 1997; Kruman et al., 2000;
Ho et al., 2003) with an inverse relationship between plasma
folate and homocysteine concentrations (Selhub et al., 1993).
Importantly, the methylation of deoxyuridine monophos-
phate (dUMP) to thymidylate (TMP) requires folic acid. Under
conditions of folate depletion, a block in the methylation of
dUMP to TMP increases intracellular deoxyuridine triphosphate
(dUTP) by several orders of magnitude while concomitantly de-
oxythymidine triphosphate (dTTP) levels drop (Goulian et al.,
1980b). Furthermore, a deficiency in folate has been reported to
lead to an increase in genome instability (Beetstra et al., 2005),
possibly the result of uracil misincorporation into DNA in pro-
liferating cells and the subsequent formation of A:Umismatches.
In addition, spontaneous hydrolytic deamination of cytosine
both in proliferating and in differentiated cells also results in
erroneous uracil residues in the form of U:G mispairs (Barnes
and Lindahl, 2004). Base excision repair replaces these uracil
bases (Friedberg et al., 2006). Uracil-DNA N-glycosylase (UNG)
is the most widely distributed glycosylase that removes uracil
from single- as well as double-stranded DNA (Kavli et al., 2002).
We have previously demonstrated that UNG is of major impor-
tance for brain tissue repair after transient brain ischemia (En-
dres et al., 2004, 2005).
Here, we tested the hypothesis that neuronal dysfunction in-
duced by chronic folate deficiency is aggravated in the absence of
efficient uracil excision repair. We demonstrate significant alter-
ations on themolecular, neurochemical, histological, and behav-
ioral levels with distinct interactions between Ung genotype and
folate deficiency.
Materials andMethods
Cell culture
Primary neuronal cultures of cerebral cortex or hippocampus were ob-
tained from mouse embryos [embryonic day 16 (E16) to E17] as de-
scribed previously (Harms et al., 2000). Briefly, cortices and hippocampi
were dissected, trypsinized, dissociated, and plated in 24-well plates pre-
coated with poly-L-lysine (0.5%w/v in PBS) and collagen (0.03%w/v) at
a density of 200,000 cells/cm2. Cultures were kept at 36.5°C and 5%CO2
andwere fed beginning from4d in vitro (DIV4)with cultivationmedium
(starter medium without glutamate) by replacing half of the medium
twice a week. DMSO was used as the vehicle for methotrexate treatment
(final concentration of 0.003% in all cultures), which was begun on
DIV8. Additional cultures were exposed to 100 M homocysteine (HC;
Sigma-Aldrich) beginning on DIV8. Folate (FA; Sigma-Aldrich) was
added to the cultivation medium, resulting in an increase of folate con-
centrations by 2.5- and 10-fold. Baseline concentration was 4mg/L (10
M), and cultures were supplemented with 25 and 100 M FA. Staining
with propidium iodide (PI) was performed for assessment of cell viability
(1 g/ml for 20 min at 37°C). Phase-contrast pictures from randomly
chosen high-power fields fromdifferent cultures were taken and counted
by a naive researcher as dead (PI-positive) or viable. Approximately 6000
neurons per condition were counted within five randomly taken high-
power fields from three independent experiments. Aliquots of the me-
diumwere collected for analysis of lactate dehydrogenase (LDH) activity
as described previously (Harms et al., 2000). Additionally, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay,
which measures the amount of blue formazan produced by viable mito-
chondria from MTT (Sigma-Aldrich), was performed at 72 h.
Mice, diets, and measurement of plasma homocysteine/methionine
The generation of mice deficient in Ung has been described previously
(Endres et al., 2004). Folate deficiency was induced as described previ-
ously (Endres et al., 2005). For selective intestinal decontamination, ex-
perimental diets (Altromin control diet C1000 and Altromin special diet
C1027 lacking folic acid) were supplemented with 1% succinylsulfathia-
zole (Sigma-Aldrich). All animals were kept on a 12 h light/dark schedule
with ad libitum access to their respective diet and water. All applicable
local and federal regulations for animal welfare were followed. The ex-
perimental protocol was approved by local authorities (Landesamt fu¨r
Arbeitsschutz, Gesundheitsschutz und technische Sicherheit Berlin). Se-
rum homocysteine levels were determined by HPLC using a homocys-
teine reagent kit for HPLC in serum (Chromosystems). Methionine was
determined on the LC 3000 amino acid analyzer (Eppendorf-Biotronik).
Immunohistochemistry, quantification, and imaging
After the experiments were completed, animals were deeply anesthetized
with ketamine and perfused transcardially with 4% paraformaldehyde in
0.1 M phosphate buffer. Tissue was essentially processed as described
previously (Katchanov et al., 2001; Kronenberg et al., 2005). Briefly, after
fixation in 4% paraformaldehyde in 0.1 M phosphate buffer over 48 h,
brains were transferred to 30% sucrose for dehydration. Brains were cut
in the coronal plane in 40-m-thick sections and cryoprotected. Sections
were stained free floating with all antibodies diluted in Tris-buffered
saline containing 3% donkey serum and 0.1% Triton X-100. Primary
antibodies were applied in the following concentrations: anti-
bromodeoxyuridine (BrdU; rat, 1:500;Harlan Seralab), anti-S100 (rab-
bit, 1:2500; Swant), anti-NeuN (mouse, 1:100; Millipore Bioscience Re-
search Reagents), anti-doublecortin (DCX; goat, 1:200; Santa Cruz
Biotechnologies), and anti-calretinin (rabbit, 1:250; Swant).
Immunohistochemistry. Immunohistochemistry followed the peroxi-
dase method with biotinylated secondary antibodies (all 1:500; Jackson
ImmunoResearch Laboratories), ABC Elite reagent (Vector Laborato-
ries), and diaminobenzidine (Sigma) as chromogen.
Immunofluorescence. For immunofluorescence, FITC-, RhodX-, or
Cy5-conjugated secondary antibodies were all used at a concentration of
1:250. Fluorescent sections were coverslipped in polyvinyl alcohol with
diazabicyclooctane as antifading agent.
Cell counts. Cell counts were determined in one-in-six series of sec-
tions covering the entire hippocampus in its rostrocaudal extension with
the peroxidase/diaminobenzidine method. The optical fractionator
principle was modified in that only cells in the uppermost focal plane (at
40 magnification) were excluded to avoid oversampling (Kronenberg
et al., 2003). For phenotypic analysis of BrdU-labeled cells, 50 randomly
selected cells per animal were analyzed for costaining with mature neu-
ronal marker NeuN or astrocytic marker S100 using a spectral confocal
microscope (TCS SP2; Leica). Appropriate gain and black level settings
were determined on control slices stained with secondary antibodies
alone.
The procedure for quantification of pyramidal neurons in the hip-
pocampal cornu ammonis (CA) was essentially identical to those de-
scribed previously (Furukawa et al., 1997). Briefly, pyramidal cells in
hematoxylin and eosin (H&E)-stained brain sections of CA1 and CA2/3
were sampled and numerical density calculated by dividing the number
of neurons counted by the reference space. Pyramidal cells of CA1 were
distinguished from those of CA2/3 by their smaller size and by the fact
that they are more tightly packed (Kruman et al., 2002). Similarly, neu-
ronal density was measured in deep frontoparietal cortical layers (V, VI)
as described previously (Yanamoto et al., 2005) (see Fig. 2D). Numerical
density was also evaluated in the basolateral complex of the amygdala,
which is easily identified by internal landmarks (i.e., amygdalar capsule,
external capsule) (see Fig. 2E) and consists of two major nuclei, the
lateral nucleus and the basolateral nucleus (Millhouse and DeOlmos,
1983). Glial cells were excluded from the counts on the basis of size and
cytological characteristics (von Bohlen und Halbach and Unsicker,
2002).
Quantification of reduced glutathione levels
Frozen tissue samples were homogenized in 10mMEDTA buffer, pH 7.0,
using a VirTis VirSonic Ultrasonic Cell Disruptor 100. After centrifuga-
tion at 14,000 rpm, at 4°C for 15 min, supernatants were aliquoted for
measurement of glutathione (GSH) levels, and the remaining cellular
pellet was retained for analysis of uracil misincorporation (see below).
Pellets were stored at 80°C until subsequent extractions were per-
formed. The protein concentration in each sample was determined using
a Bio-Rad protein assay kit (Bio-Rad).
7220 • J. Neurosci., July 9, 2008 • 28(28):7219–7230 Kronenberg et al. • Neurodegeneration by Folate Deficiency
GSH levels were essentially quantified as described previously
(Cardozo-Pelaez et al., 2000). Briefly, protein was precipitated in 6.5%
sulfosalicylic acid, and nonprotein thiol content was quantified after
centrifugation at 10,000 rpm, at 4°C for 10min. Supernatantswere added
to a reaction mixture containing 2-nitro-5-thiobenzoic acid as chromo-
gen. Absorbance was measured at 412 nm using a SpectraMax 340 96-
well plate reader (Molecular Devices). GSH content was determined by
comparison with standards of known amounts of GSH. Data were ex-
pressed as nanomoles of GSH per milligram of protein.
HPLC analysis of 2-deoxyuridine
2-Deoxyuridine (2-dU) levels were quantified from remaining nuclear
pellets by preparing and resolving purified DNA into deoxynucleoside
components as described previously (Bolin et al., 2006). The amount of
2-dU and 2-deoxyguanosine (2-dG) was calculated by comparing the
peak area of 2-dU and 2-dG obtained from 150 l of injected enzymatic
hydrolysate of DNA sample to a calibration curve for both nucleosides.
HPLC analysis was based on a modification of a previously published
method (Hailer et al., 2005). Nucleosides were separated using a reverse-
phase C18 Omnisphere 4.6 250 mm with a 5 m particle size column
(VARIAN) and a water:acetonitrile mobile phase at a flow rate of 1 ml/
min with an increasing acetonitrile gradient of 0.5% per minute using a
Model 600S Solvent Delivery Module (Waters). 2-dU and 2-dG were
detected by a Model 996 Photodiode Array Detector (Waters). Nucleo-
side identity was corroborated by comparison of retention time and
absorbance spectrum of samples and pure standards. Peak areas were
monitored at 260 for 2-dU, and 290 for 2-dG with the data recorded,
stored, and analyzed on a PC Pentium computer using Millenium32
Software version 3.05.01 (Waters). Data were expressed as nanograms of
2-dU per micrograms of total DNA. Total DNA (in micrograms) was
calculated based on the relationship that 1 g of DNA contains 0.648
nmol of 2-dG (Cardozo-Pelaez et al., 1998).
Quantification of cerebral neurotransmitter and BDNF levels
Hippocampus, striatum, frontal cortex, parietal cortex, amygdala, and
motor and somatosensory cortex were dissected on a cold plate (16°C)
according to Franklin and Paxinos (1997). Samples were weighed and
stored at80°C. Frozen tissue samples were homogenized by ultrasoni-
cation in 20–50 vol of deionized water at 4°C. Immediately after son-
ication, an aliquot of the homogenate (200–300 l) was added to an
equal volume of 0.2 N perchloric acid and centrifuged at 25,000 g for
10 min at 4°C. The supernatant was used for the measurement of 5-HT,
5-hydroxyindoleacetic acid (5-HIAA), and norepinephrine (NA). For
the determination of BDNF levels as described below, another aliquot of
the homogenate was added to an equal volume of lysing buffer contain-
ing 0.1 M Tris-HCl, pH 7.0, 0.4 M NaCl, 0.1% NaN3, and a variety of
protease inhibitors as contained in Protease Inhibitor Tablets (“com-
plete”; purchased from Roche Diagnostics) and was stored at 80°C
until analysis. 5-HT and 5-HIAA were analyzed as described previously
(Sperk, 1982) using HPLC with electrochemical detection. NA was mea-
sured by HPLC with electrochemical detection after extraction to alu-
mina according to a previously published protocol (Felice et al., 1978)
with minor modifications (Sperk et al., 1981).
Endogenous levels of BDNF were measured in the rethawed homoge-
nates using commercial ELISA kits in principle according to the manu-
facturer’s instructions (Promega) but adapted to a fluorometric tech-
nique as described in detail previously (Hellweg et al., 2003). BDNF
content was expressed as equivalents of recombinant human BDNF. The
detection limit of the assay was 1 pg/ml. Determinations of recovery and
specific and unspecific neurotrophin binding (the latter against mouse
IgG1 obtained fromMOPC 21) involved quadruplicate fluorescence de-
terminations for each tissue sample. Using this improved fluorometric
ELISA, it was feasible to quantify BDNF in brain tissue with a minimal
wet weight of 5 pg (Hellweg et al., 2003, 2006). BDNF levels were
expressed as picograms per milligram of tissue (wet weight).
Big Blue transgenic mouse mutation detection assay
Analyses were performed in mice after 3 months of folate depletion and
inmouse embryonic fibroblasts (MEFs). PrimaryMEFs were cultured in
folate-deficient, high-glucose DMEM (Invitrogen) supplemented with
10% FBS, Glutamax, and the antibiotics penicillin and streptomycin
(Invitrogen). High-molecular-weight genomic DNA was isolated and
mutationswithin the cII genewere scored essentially aswe have described
previously (Endres et al., 2004).
Behavioral tests
Behavioral tests were performed in principle as described previously
(Winter et al., 2004, 2005). All behavioral analyses were performed dur-
ing the dark (i.e., active) phase of a 12:12 h light–dark cycle.
Spontaneous activity. Spontaneous activity was assessed essentially as
described previously (Winter et al., 2005). Briefly, animals were individ-
ually placed in single cages (30 20 15 cm) evenly distributed across
rows and columns for each group in a “checkerboard” manner. Animals
from different groups were placed in alternating order to control for a
position effect. Time, speed, and distance of spontaneous activity was
measured overnight over a period of 8 h. Dim, indirect illumination in a
neutral setting of a soundproof chamber provided uniformand sufficient
light for automated detection of movements using PC-based VideoMot
System software (TSE Systems). Here, the sampling rate was set at 1 Hz,
and activity was defined as a movement of the center of gravity of the
mouse0.4 cm.
Morris water maze. The Morris water maze task was used to assess
spatial learning andmemory. Experiments were adapted frompreviously
published protocols with minor modifications (Harker and Whishaw,
2002; Winter et al., 2004). A 160-cm-diameter, 60.5-cm-high swimming
pool with cues present at fixed positions was filled to a depth of 29 cm
with 21°C opaque water. A clear Plexiglas platform (10  10 cm) was
submerged at a fixed position with the top located 0.5 cm beneath the
surface of the water in the center of one of the four quadrants. Swimming
performance (e.g., speed, latency, distance) was tracked with a
computer-based system (TSE Systems). The experiment consisted of a
place task (acquisition period) with 3 trials/d for 8 consecutive days and
a probe trial (spatial probe) on day 9. Each trial consisted of maximally
90 s starting from one of the three remaining quadrants with the face of
the animal facing the wall. If after 90 s an animal did not reach the
platform, it was guided to the platform. After reaching the platform,
animals were allowed to remain there for 30 s. The intertrial interval was
1 min, and mice were quickly dried with a towel and placed under a
heating lamp at exactly 37°C between each trial to avoid hypothermia. In
the place task, the latencies, path lengths, and swim speeds for a single day
were averaged to come up with a daily mean. For the probe trial, the
platform was removed, and mice were allowed to swim for 90 s.
Elevated plus maze. The elevated plus maze apparatus was made of
black Plexiglas and consisted of two opposite open arms (30 5 0.25
cm) and two enclosed arms (30  5  15 cm) with side and end walls.
The arms extend from a central platform (5 5 cm) and are elevated 50
cm above the floor standing on a tripod. Open-arm exploration was
encouraged by testing under dim evenly distributed indirect light. At the
beginning of the test, each mouse was placed in the center of the maze
facing one of the closed arms. Time spent on the open arms was used as
an index of anxiety (Winter et al., 2005).
Porsolt’s forced-swim test. The modified version of Porsolt’s forced-
swim test was performed at the end of behavioral testing as described
previously (Winter et al., 2005). Briefly, mice were placed individually in
glass cylinders (15 21 cm) filled with water (22°C) up to a height of 8.5
cm. Behaviors weremonitored for a period of 300 s using a time sampling
technique for subsequent analysis. Climbing behavior consisted of
upward-directed movements of the forepaws along the side of the cylin-
der. Immobility was defined as motionless floating in the water with no
additional activity other than that required to keep the head above the
water.
Statistical analysis
Experiments were performed in a blinded manner. Values are presented
as mean  SEM. Statistical comparisons were performed by two-way
ANOVA with level of significance set at 0.05 and two-tailed p values.
Tukey post hoc testing was performed where appropriate. Water maze
performance in the place task was analyzed by ANOVA with repeated
measurements.
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Results
Neurodegeneration induced by
folate deficiency
Folate depletion induces cell death in
Ung/ neurons
The effect of folate depletion was analyzed
in primary neocortical and hippocampal
Ung/ and Ung/ neurons (Fig. 1A–
D). To do so, cells were exposed to the
dihydrofolate-reductase inhibitor metho-
trexate (MTX). Cell death was quantified
by measurement of LDH release into the
medium, by counting healthy neurons in
vitro, as well as by measuring MTT as a
metabolic activity marker. There was only
borderline vulnerability to MTX in
Ung/ neurons, whereas MTX treat-
ment resulted in major cell death of corti-
cal and, even more so, hippocampal
Ung/ neurons. Notably, a significant
genotype treatment interaction for LDH
release, percentage of viable neurons, and
MTTmetabolism was evident in both cor-
tical and hippocampal cultures (for statis-
tical analysis, see Fig. 1).
Increased sensitivity of Ung/
hippocampal neurons to homocysteine is
alleviated by increasing concentration of
folate in culture
Hyperhomocysteinemia mediates many of
the major metabolic sequelae of low-folate
status. Here, we tested how increasing fo-
late concentrations above control levels in
culture would impact the sensitivity of
Ung/ and Ung/ neurons to HC
neurotoxicity. There was only borderline
vulnerability to 100 M HC in Ung/
cortical and hippocampal neurons. In con-
trast, hippocampal Ung/ neurons
proved highly susceptible to homocys-
teine. Importantly, increasing the concen-
tration of folate in the cultivation medium
above baseline levels largely reversed this
effect (Fig. 1E–G).
Chronic folate deficiency induces selective
loss of pyramidal cells in CA3 in Ung/
mice
To test the effects of chronic folate defi-
ciency in vivo, Ung/ and littermate
Ung/ mice of 12  2 months of age
were subjected to a diet deficient in folate
(FD) versus regular diet (ND) for 3months
(Endres et al., 2005). Ung/ animals
have been described in detail previously
(Endres et al., 2004, 2005). Briefly,
Ung/mice develop normally, show no
overt phenotype, gainweight at a rate equal
to that of wild-type mice, and have normal
life spans. The effectiveness of FD was as-
certained by measurement of serum ho-
mocysteine levels. Regardless of genotype,
Figure 1. Increased cell death in Ung/ neurons to methotrexate and homocysteine: reversal by folic acid supplementa-
tion. Neocortical (CTX) and hippocampal (HIP) neurons were exposed to the dihydrofolate-reductase inhibitor methotrexate
(MTX) or vehicle.A, Increase in LDHactivity relative to vehicle-treated sister cultures. Two-wayANOVA (72h) for genotype: F(1,150)
 9.8, p	 0.001 in CTX and F(1,70) 292.3, p	 0.001 in HIP; treatment: F(1,150) 27.3, p	 0.001 in CTX and F(1,70) 69.1,
p	 0.001 in HIP; genotype treatment interaction: F(1,150) 5.2, p	 0.001 in CTX and F(1,70) 28.2, p	 0.001 in HIP. B,
MTT was measured as a metabolic activity marker and presented as loss of MTT metabolism relative to vehicle-treated sister
cultures. ANOVA for genotype: F(1,70) 0.6, p 0.5 in CTX and F(1,70) 305.5, p	 0.001 inHIP; treatment: F(1,70) 11.3, p	
0.001 in CTX and F(1,70) 101.4, p	 0.001 in HIP; interaction: F(1,70) 4.0, p 0.006 in CTX and F(1,70) 42.2, p	 0.001 in
HIP. C, D, Viable versus damaged neurons were identified by phase-contrast microscopy and propidium iodide counterstaining.
Viable neurons are presented as a percentage of all neurons/high-power field. ANOVA for genotype: F(1,40) 33.1, p	 0.001 in
CTX and F(1,40) 232, p	 0.001 in HIP; treatment: F(1,40) 35.7, p	 0.001 in CTX and F(1,40) 56.9, p	 0.001 in HIP.
Interaction: F(1,40) 9.8, p	 0.001 in CTX and F(1,40) 27, p	 0.001 in HIP. E–G, CTX andHIP neuronswere exposed to either
HC plus vehicle or HC plus FA. Basal FA concentration in Neurobasal medium is 4 mg/L (10 M). E, Increase in LDH activity
relative to vehicle-treated sister cultures. Two-way ANOVA (72 h) for factor genotype: F(1,28) 8.2, p 0.008 in CTX and F(1,28)
29.3,p	0.001 inHIP; treatment: F(1,28)3.3,p0.017 inCTXand F(1,28)13.4,p	0.001 inHIP; genotype treatment
interaction: F(1,28) 0.711, p 0.7 in CTX and F(1,28) 3.1, p 0.026 in HIP. F, G, Viable versus damaged neurons were
identified by phase-contrast microscopy and propidium iodide counterstaining. Viable neurons are presented as a percentage of
all neurons/high-power field. ANOVA for genotype: F(1,32) 0.7, p 0.40 in CTX and F(1,32) 39, p	 0.001 in HIP; treatment:
F(1,32) 1.5, p 0.25 in CTX and F(1,32) 38.1, p	 0.001 in HIP. Interaction: F(1,32) 0.5, p 0.7 in CTX and F(1,32) 10.4,
p	 0.001 in HIP. Scale bars: D, G, 50m. A–F, #p	 0.05 for neocortical and *p	 0.05 for hippocampal neurons, Ung/
versusUng/within the sameMTX, HC, or HC plus FA treatment condition. E, F, p	 0.05 versus correspondingHCwithout
FA. Baseline LDH release and MTT metabolism are given in supplemental Tables 2A (for A, B) and 2B (for E) (available at
www.jneurosci.org as supplemental material). All experiments were performed at least in triplicate.
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there was a significant increase in homocysteine levels (in micro-
moles per liter) as an effect of treatment (Ung/ND, 8.5 2.4;
Ung/ ND, 9.6  1.4; Ung/ FD, 67  29.9; Ung/ FD,
49.9 20.1).Methionine levels did not differ across groups (data
not shown). Body weight (in grams) after 3 months of folate-
deficient diet was also similar across groups (Ung/ ND,
31.9  1.5; Ung/ ND, 31.2  2; Ung/ FD, 30.2  1.1;
Ung/ FD, 31.6 0.8).
CA3 pyramidal neurons are particularly vulnerable to DNA
damage and excitotoxicity (Nadler et al., 1980; Furukawa et al.,
1997; Kruman et al., 2002). We therefore quantified neuronal
density in CA3. Examination of H&E-stained sections of hip-
pocampus revealedmassive degeneration of CA3 pyramidal neu-
rons in Ung/ mice that had been maintained on the folate-
deficient diet (Fig. 2A,B). However, the
effects on CA3 pyramidal cell density of
either folate deficiency or Ung/ geno-
type alone remained subthreshold. Two-
way ANOVA and Tukey post hoc testing
demonstrated that CA3 cell loss was signif-
icantly increased in folate-deficient
Ung/ mice compared with the other
experimental groups (Fig. 2B). Loss of
CA3 neurons was selective as demon-
strated by stereology-based assessment of
neuronal densities in CA1 (Fig. 2C), deep
layers (V, VI) of frontoparietal cortex (Fig.
2D), and basolateral complex of amygdala
(Fig. 2E), which did not yield significant
differences among the four experimental
groups.
Effect of folate deficiency on brain 2-dU
levels in Ung/ versus Ung/mice
Previous studies have indicated a critical
role for base excision repair of misincor-
porated uracil in neuronal survival (En-
dres et al., 2004, 2005; Kruman et al.,
2004). Misincorporation of 2-dU into
DNA was quantified in homogenates of
whole cerebral hemispheres. 2-dU levels
were significantly elevated in Ung/
compared with Ung/ mice and were
further increased by folate deficiency (Fig.
3A).
Folate deficiency decreases hippocampal
BDNF levels in Ung/ mice
BDNF signaling promotes neuronal sur-
vival (Thoenen, 1991; Soriano et al., 2006),
and decreased hippocampal BDNF ex-
pression has been linked to depressive be-
haviors in mice (Ridder et al., 2005). Here,
BDNF expression was measured at the
protein level.We observed a significant ge-
notype  treatment interaction (F(1,31) 
16.6; p	 0.0005) with reduced hippocam-
pal BDNF levels in Ung/ mice receiv-
ing folate-deficient chow but increased
BDNF expression in folate-deficient wild-
type mice andUng/mice receiving the
control diet (Fig. 3B). Elevated amygdalar
BDNF levels have been linked specifically
to increased anxiety (Govindarajan et al.,
2006). Here, BDNF levels in amygdala (in
picograms per milligram of wet weight) were significantly in-
creased as an effect of Ung/ genotype (Ung/ ND, 41.7
2.8;Ung/ND, 62.5 6.1;Ung/ FD, 53.1 4.6;Ung/
FD, 61.7 7.6).
Folate deficiency decreases reduced-form GSH levels in
Ung/ mice
GSH is the major cellular buffer against reactive oxygen species
(ROS). Loss of mitochondrial GSH and the subsequent increase
in ROS production are associated with induction of apoptosis
(Tan et al., 1998; Armstrong et al., 2002). GSH levels decrease
after severe brain damage [e.g., after ischemia/reperfusion (Park
et al., 2000)], whereas “compensatory” GSH increases may indi-
Figure 2. Increased susceptibility of Ung/mice to neurodegeneration after chronic folate depletion in vivo. A, Represen-
tative images of 10-m-thick H&E-stained sections illustrating reduced neuronal density in CA3 of Ung/ animals as a
consequenceof chronic folatedeficiency (bottomright).B, Density of CA3pyramidal neurons; ANOVA for genotype: F(1,16)22.8,
p	 0.0005; treatment: F(1,16) 11.3, p	 0.005; interaction: F(1,16) 3.8, p 0.068; 1- 0.44. C–E, Similar neuronal
densities in other brain regions. C, Hippocampal subfield CA1. D, Deep cortical layers of frontoparietal cortex. E, Basolateral
complex of amygdala. ec, External capsule; int, internal capsule; amc, amygdalar capsule. *p	 0.05, ND versus FD; #p	 0.05,
Ung/ versus Ung/.
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cate milder chronic oxidative stress (Shea et al., 2004; Tchant-
chou et al., 2005). Here, chronic folate deficiency decreased GSH
levels (in nanomoles per milligram of protein) in whole brain
hemispheres and profoundly in cerebella of Ung/ but not
Ung/ mice (Fig. 3C,D). Importantly, a similar pattern was
observed in the heart (Ung/ ND, 10.2  0.8; Ung/ ND,
9.4  1.0; Ung/ FD, 9.0  1.0; Ung/ FD, 4.1  1.1) and
kidneys (Ung/ ND, 40.1  6.7; Ung/ ND, 40.3  6.7;
Ung/ FD, 39.1 4.0, Ung/ FD, 29.2 3.9).
Folate depletion increases mutant frequency in
embryonic fibroblasts
Ung/ and Ung/mice were established on a homozygous
Big Blue (Stratagene) background. Spontaneous mutation fre-
quencies in the cll gene were similar in Ung/ compared with
Ung/MEFs (Endres et al., 2004). Folate deficiency conferred
increased mutant frequency in bothUng/MEFs andmore so
Ung/MEFs compared with normal medium (Fig. 4A).
Folate depletion effect on mutant frequency in brains from
Ung/ and Ung/mice
Ung/(BigBlue) and Ung/(BigBlue) mice were fed a nor-
mal or a folate-deficient diet for 3 months. Overall, spontaneous
mutant frequencies in the cll gene were similar in brain tissue
isolated from both Ung/ and Ung/ mice. In contrast to
the findings in MEFs, folate deficiency conferred no relevant in-
crease in mutant frequencies in either the Ung/ or Ung/
brains (Fig. 4B).
Effects of folate depletion on neurotransmitter levels: folate
deficiency decreases brain 5-HIAA/5-HT ratio independent of
Ung genotype
Altered monoamine neurotransmitter metabolism has been
identified in psychiatric patients with folate deficiency
(Bottiglieri et al., 2000). In particular, low levels of serotonin
metabolites were observed in the CSF of patients suffering
from folate-responsive neuropsychiatric disease (Botez et al.,
1982). The 5-HIAA/5-HT ratio is considered a sensitive index
of utilization of 5-HT (Shannon et al., 1986). We observed an
overall trend of lower 5-HIAA/5-HT ratios in folate-deficient
animals, which was statistically significant in amygdala and
striatum (supplemental Table 1, available at www.
jneurosci.org as supplemental material). 5-HIAA levels were
also significantly reduced in hippocampus, amygdala, and
striatum of folate-deficient animals (Fig. 5A). In addition,
folate deficiency caused a significant increase in norepineph-
rine levels in amygdala and hippocampus (Fig. 5B). Together,
the effects of folate deficiency on neurotransmitter metabo-
lism were largely independent of Ung genotype.
Effect of chronic folate deficiency on neurogenesis: folate
deficiency impairs adult hippocampal neurogenesis largely
independent ofUng genotype
The effects of folate deficiency and impaired uracil excision repair
were also investigated in proliferating neural precursor cells in
vivo. Neurogenesis in the adult hippocampal dentate gyrus is a
complex process regulated at a number of different levels (Kem-
permann et al., 2004). The number of BrdU-positive cells after a
6 d course of single daily intraperitoneal injections of BrdU, the
number of DCX-immunoreactive cells, and the number of
calretinin-immunoreactive cells were used to assess early steps of
neurogenesis (Fig. 6A). Animals had been placed on either a
folate-deficient or control diet 3 months before they were killed.
In this particular injection paradigm, BrdU numbers are a broad
measure of cell proliferation. DCX immunoreactivity reflects
neuronal lineage determination (Brown et al., 2003; Rao and
Shetty, 2004), and calretinin is used as a marker of early postmi-
totic granule cells (Brandt et al., 2003). Consistently, folate defi-
ciency led to a significant decrease of all these measures. An ad-
ditional genotype effect on the level of DCX-immunoreactive
Figure 3. Biochemical consequences of folate deficiency and Ung genotype. A, Uracil misin-
corporation in DNA; ANOVA for genotype: F(1,29) 5.6, p 0.02. B, BDNF protein levels in
hippocampus; ANOVA for interaction: F(1,31) 16.6, p	 0.0005. C, GSH levels in whole cere-
bral hemispheres; ANOVA for interaction: F(1,20) 5.6, p 0.03. D, GSH levels in cerebellum;
ANOVA for interaction: F(1,20) 20.4, p 0.0002. *p	 0.05, ND versus FD;
#p	 0.05,
Ung/ versus Ung/; p	 0.05 for interaction; two-way ANOVA and Tukey post hoc;
n 5–9 animals per group.
Figure4. Folate deficiency confers increasedmutant frequencies inMEFs but not in brains of
Ung/mice. A, Mouse embryonic fibroblasts were cultured in folate-deficient medium for
6 d. Average mutant frequencies at the  cII gene (left) and individual measurements (table)
are shown. B, Ung/(BigBlue) and Ung/(BigBlue) mice were fed a normal or a folate-
deficient diet. Average mutant frequencies in brain tissue were assessed after 3 months. Indi-
vidual measurements are given in the table. pfu, Plaque-forming unit; MF, mutant frequency.
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cells emerged with lower numbers observed inUng/ animals
(F(1,14) 5.7; p 0.03, post hoc test, Ung/ vs Ung/, p
0.03).
Net neurogenesis was analyzed 4 weeks after a 7 d course of
single daily intraperitoneal injections of BrdU. Animals were
placed on their respective diets 3 months before they were killed
and 2months before BrdU injections. In this injection paradigm,
BrdU counts reflect a combination of initial proliferation and
subsequent survival of newly generated cells. BrdU cell counts
were significantly reduced as an effect of folate deficiency (Fig.
6B) with no apparent effect of the genotype. BrdU-labeled cells
were subjected to further phenotypic analysis. The majority of
cells did not show colabeling with either astrocytic marker S100
or neuronal marker NeuN. Across groups, we did not observe a
significant difference in the phenotypes of newly generated cells
(Fig. 6B–D).
Behavioral consequences of chronic folate deficiency
Folate deficiency impairs spatial learning
We analyzed the effects of folate deficiency in the Morris water
maze, a hippocampus-dependent task modeling declarative
learning and memory (Morris, 1984). In the place task (days
1–8), there was a significant effect of folate-deficient diet and
number of trial on escape latency (F(1,37)  5.46, p  0.25;
F(7,259)  27.9, p 	 0.0001, respectively; repeated-measures
ANOVA) and distance (F(1,37) 5.03, p 0.31; F(7,259) 26.0,
p 	 0.0001, respectively) (Fig. 7A,B). Ung/ FD mice
showed inferior performance in the place task compared with
the other groups, which, however, did not reach statistical
significance. Similarly, in the probe trial there was a trend for
fewer target crossings (Ung/ ND, 6  1.1; Ung/ ND,
5.5  0.8; Ung/ FD, 5  1.3; Ung/ FD, 3.6  0.7) and
lower target preference (Fig. 7C) in the folate-deficient
Ung/ group.
Folate deficiency induces an anxious phenotype and despair-like
reactions in Ung/ mice
In the Porsolt forced-swim test, latency to float (i.e., the time to
“give up”) and the total time floating are measures of despair-
related behavior (Cryan et al., 2002). Therewas a significant effect
of genotype on latency to float and total time floating.
Post hoc testing revealed that this effect was significant in
folate-deficient Ung/ mice only ( p 	 0.005 for latency and
total time floating) (Fig. 7D,E).
The elevated plus maze is a behavioral assay based on an
approach-avoidance conflict to test anxiety-related behavior.
Two-way ANOVA revealed a significant effect of genotype on the
number of open arm visits and time spent on the open arms
[number of open arm entries: Ung/ND, 9.8 1.5; Ung/
ND, 4.9 1.2; Ung/ FD, 6.1 0.9; Ung/ FD, 4.4 1.3;
Tukey post hoc test for factor treatment within wild-type mice
only, p	 0.05; factor genotype, p	 0.05; factor genotype within
control diet, p	 0.05; time (in seconds) spent on the open arms:
Figure 5. Folate deficiency effects on neurotransmitter metabolism. A, Tissue content of
5-HIAA and of 5-HT. B, NA levels in amygdala and hippocampus. Tissue contents are reported
permilligramofwetweight. *p	 0.05, ND versus FD; #p	 0.05,Ung/ versusUng/.
n 8–10 animals per group.
Figure 6. Hippocampal neurogenesis. A, Early steps of neuronal development in the adult
dentate gyrus were assessed after 3 months of treatment (control or folate-deficient diet). Cell
proliferation was quantified after a 6 d course of once daily intraperitoneal BrdU before the
animals were killed. Doublecortin-expressing cells reflect neuronal lineage determination,
whereas calretinin represents a marker of early postmitotic granule cells in the hippocampal
dentate gyrus.n5animals per group.B, To characterize the effects of folate deficiency on the
fate of newly generated cells, animals received a 7 d course of once daily intraperitoneal BrdU 8
weeks after initiation of treatment (control or folate-deficient diet) and 4 weeks before the
animalswerekilled.NeuronalmarkerNeuN (green inC) andastrocyticmarker S100 (blue inD)
were used for phenotypic analysis of BrdU-positive (red in C andD) cells. n 8–10 animals per
group. C, A three-dimensional reconstruction of a z-series through a NeuN cell along the y–z
axis (right narrow panel) and x–z axis (bottom narrow panel), which confirms that BrdU and
NeuN are present in the same cell. Scale bar, 15m.D, A newly generated S100 astrocyte.
Scale bar, 5m. *p	 0.05, ND versus FD; #p	 0.05, Ung/ versus Ung/.
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Ung/ ND, 9.7  1.7; Ung/ ND, 6.3  1.3; Ung/ FD,
16.1 4.7; Ung/ FD, 6.6 2.3; post hoc for factor genotype,
p	 0.05; post hoc for factor genotype within folate-deficient an-
imals, p 	 0.05]. Similarly, folate-deficient Ung/ mice dis-
played a longer latency to enter the open arms compared with
controls (Fig. 7F). Furthermore, two-way ANOVA revealed sig-
nificant effects of both genotype and treatment on total distance
moved (in centimeters) during the task (Ung/ ND, 1524 
126; Ung/ ND, 1056  86; Ung/ FD, 1096  135;
Ung/ FD, 906 105; post hoc for factor genotype, p	 0.01;
post hoc for factor treatment, p	 0.05). The amount of time (in
seconds) spent in the center of the plus maze apparatus did not
differ significantly across groups (Ung/ ND, 52.2  12.4;
Ung/ND, 41.9 9.7;Ung/ FD, 29.9 4.4;Ung/ FD,
45.9 17.1). Although one-way ANOVA of the total number of
entries (open and closed arms) demonstrated a significant differ-
ence between Ung/ ND and Ung/ FD, two-way ANOVA
for factors genotype and treatment did not yield significant ef-
fects (Ung/ ND, 40.4  5.8; Ung/ ND, 29.2  3.8;
Ung/ FD, 28.7 3.3; Ung/ FD, 24.1 17.1).
Increased spontaneous locomotion has been reported in very
different paradigms of brain damage, including transient isch-
emia, some forms of neonatal excitotoxic lesions, traumatic brain
injury, or intrauterine exposure to toxins (Johns et al., 1982; Le-
wen et al., 1999; Flores et al., 2005; Winter et al., 2005). Animals
were monitored for spontaneous activity in individual cages (to-
tal of 8 h overnight) in principle as described previously (Winter
et al., 2005). Spontaneous activity (in minutes) was as follows:
Ung/ND, 42.8 5.2;Ung/ND, 46.7 6.5;Ung/ FD,
61.1  12.2; Ung/ FD, 57.9  4.5 (two-way ANOVA for
factor diet, p 0.06). Similarly, the distance moved (in centime-
ters) was also increased in folate-deficient animals:Ung/ND,
3936  527; Ung/ ND, 4703  949; Ung/ FD, 6568 
1624; Ung/ FD, 7276  1476 (two-way ANOVA for factor
diet, p 0.06).
Discussion
We here show that impaired uracil excision repair contributes to
neurodegeneration and brain dysfunction induced by folate de-
pletion: exposingmice to a folate-deficient diet induced cognitive
dysfunction and an anxious, despair-related phenotype, which
was aggravated in animals lacking UNG. In vitro, folate antago-
nist methotrexate conferred cell death primarily inUng/ hip-
pocampal neurons. In vivo, only the combination of Ung/
genotype and folate depletion caused neurodegeneration in CA3,
which was accompanied by decreased BDNF and GSH levels.
These results identify uracil misincorporation as an important
pathogenic mechanism of folate deficiency. However, not all ef-
fects of folate deficiency were found to be a function of Ung
genotype. The reduction in hippocampal neurogenesis and met-
abolic sequelae like hyperhomocysteinemia and changes in
monoamine levels were not prominently affected by Ung
deficiency.
Neuronal populations even within a single brain region may
show different susceptibility to different kinds of an insult. Strik-
ingly, hippocampal neurodegeneration in folate-deficient
Ung/ mice was selective to CA3, as opposed to CA1 and ad-
ditional brain areas investigated. This observation fits well with
results from cell culture demonstrating greater susceptibility of
primary hippocampal compared with cortical neurons to meth-
otrexate or homocysteine. An earlier study of folate deprivation
in amyloid precursor protein mutant transgenic mice likewise
reported selective vulnerability of CA3 pyramidal neurons (Kru-
man et al., 2002). Converging evidence suggests that selective
neuronal loss in CA3might result from a specific vulnerability of
these neurons to DNA damage and/or excitotoxicity, also in old
age (Nadler et al., 1980; Mattson et al., 1992; Kesslak et al., 1995;
Furukawa et al., 1997).
Folate deficiency increased mutant frequencies in Ung/
MEFs but not in brains of either Ung/ or Ung/ mice.
However, data from cell lines cannot be correlated directly with
in vivo data, because the impact of folate deficiency on an organ-
ism involves major metabolic changes throughout. Also, the me-
tabolism ofMEFs compared with postmitotic neurons will differ.
Furthermore, an increase inmutations is likely observed inMEFs
because they show greater resilience. In contrast, especially
Ung/ hippocampal neurons proved highly sensitive to folate
deprivation. It is therefore likely thatmore severely damaged cells
inUng/ brains degenerate before accumulation of mutations
is observed.
Whereas the contribution of UNG deficiency was minor, fo-
late deficiency strongly repressed neurogenesis, indicating simi-
lar cytotoxicity through uracil misincorporation (in Ung/)
Figure 7. Behavioral analysis. Behavioral analyses were performed after 3 months on the
experimental diet (control or folate-deficient diet). A, B, Latencies (A) and path lengths (B) of
Ung/ and Ung/ animals on folate-deficient or control diet during the acquisition
phase of the Morris water maze. There were significant effects of diet and trial number on
escape latency and path length (repeated-measures ANOVA; see Results). C, Target preference
during probe trial. D, E, Latency to float (D) and time floating (E) in the behavioral despair test
(Porsolt). F, Latency until first entry into the open arms of an elevated plus maze. #p	 0.05,
Ung/ versus Ung/. n 6–14 animals per group. For statistical analysis, see Results.
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and base excision repair of misincorporated uracil (in Ung/)
in hippocampal progenitors. Phenotypes of newborn cells did
not differ across groups. A large fraction of BrdU cells lacked
colabeling with neuronal or glial markers, in line with an earlier
study in aged mice (Kempermann et al., 2002). Importantly, a
significant decrease in neurogenesis has been reported long be-
fore an animal becomes aged (Heine et al., 2004; Leuner et al.,
2007). Mechanisms underlying reduced cell proliferation under
low-folate conditions likely involve hyperhomocysteinemia, in-
hibition of methyltransferase reactions, and decreased signaling
through Ras pathways. Decreased Ras signaling through inhibi-
tion of carboxyl methylation mediates MTX’s antiproliferative
effect largely independent of thymidine biosynthesis (Winter-
Vann et al., 2003). In line with our results, folate deficiency in-
hibits both proliferation of cultured fetal multipotent neuroepi-
thelial cells and cell proliferation in the dentate gyrus in vivo
(Kruman et al., 2005). In contrast, in postmitotic neurons folate
deficiency (ormethotrexate) alone did not have a strong effect on
cell survival, whereas the combination of folate deficiency and
Ung knock-out proved detrimental. Together, our results indi-
cate that under low-folate conditions, defective uracil repair con-
tributes to cell death in postmitotic differentiated cells, whereas
the effects on proliferation are largely independent of base exci-
sion repair.
Here, 2-dU levels were significantly elevated in Ung/
compared with Ung/mice and were further increased by fo-
late deficiency. During folate deficiency, levels of dTTP are de-
pleted, whereas levels of dUTP increase (Goulian et al., 1980a).
Mechanisms of uracil misincorporation resulting from folate de-
ficiency differ between proliferating and postmitotic cells. Large
quantities of dUTPmay be incorporated instead of dTTP during
S-phase (or DNA repair). The resulting A:U mismatches, how-
ever, do not result in mutations, but may hamper recognition by
DNA-binding proteins and thus alter physiological function
(Courtemanche et al., 2004). Levels of uracil in the DNA of
Ung/ cells strongly depend on proliferation (Andersen et al.,
2005). On the other hand, in mature postmitotic cells, low levels
of genomic uracil may be generated during DNA repair or di-
rectly via deamination of cytosine. The resultingG:Umismatches
are promutagenic and, if left unrepaired, lead to GC3AT tran-
sition mutations. Importantly, in the absence of
S-adenosylmethionine (induced by folate deficiency), DNA
(cytosine-5)-methyltransferase causes cytosine deamination in
double-stranded DNA (Shen et al., 1992).
The Ung gene encodes mitochondrial (UNG1) and nuclear
(UNG2) isoforms of UNG (Nilsen et al., 2000).When exposed to
brain ischemia, Ung/ animals develop enlarged lesions. The
mechanism of cell death may relate to the lack of UNG1 in mito-
chondria [comparable with the recently describedmitochondrial
mutator phenotype (Chatterjee and Singh, 2001; Trifunovic et
al., 2004; Kujoth et al., 2005)]. Indeed, the most significant in-
crease of uracil-excising activity after ischemia was seen in mito-
chondrial/cytosolic extracts and was exclusively caused byUNG1
(Endres et al., 2004). Similarly, lack of DNA repair capacity was
unmasked here as selective neurodegeneration after folate depri-
vation. We speculate that uracil misincorporation into mito-
chondrial DNA (mtDNA) and subsequent respiratory chain dys-
function is an important mechanism by which folate deficiency
causes neuronal vulnerability, e.g., by provoking a bioenergy def-
icit or by lowering the signal threshold for cell death (Trifunovic
et al., 2005). Notably, mutational damage of mtDNA, which has
been implicated in neurodegenerative disease and aging (Tan-
hauser and Laipis, 1995), decreases with folate supplementation
(Branda et al., 2002).
Clinical studies have suggested a role for folate and homocys-
teine in the pathogenesis of affective disorders (Reynolds et al.,
1970; Reynolds, 2002; Papakostas et al., 2004a,b). There is also
increasing evidence for a beneficial effect of folate in protecting
against Alzheimer’s disease and cognitive decline with age (Se-
shadri et al., 2002;Nurk et al., 2005;Durga et al., 2007; Luchsinger
et al., 2007). Therefore, it is interesting to note within this context
that in culture folate supplementation reversed increased suscep-
tibility of the Ung/ genotype to homocysteine.
The Porsolt forced-swim test is commonly used to screen for
antidepressant agents and, more recently, also to assess despair-
like behavior in rodents (Cryan et al., 2002; Bale and Vale, 2003;
Govindarajan et al., 2006; Clapcote et al., 2007; Fukui et al.,
2007). Whereas folate deficiency alone did not confer a clearly
despair-like phenotype, folate-deficient Ung/ mice demon-
strated significantly increased immobile time and reduced la-
tency to float. Similarly, in the elevated plus maze, folate-
deficient Ung/ animals spent significantly less time on the
open arms compared with controls. Importantly, these results
were attributable to an increase in specific anxious and despair-
related behaviors and not accounted for by a decrease in sponta-
neous activity in Ung/ FD.
Largely independent of genotype, folate deficiency reduced
5-HIAA levels and inhibited neurogenesis. In contrast, hip-
pocampal BDNF was specifically reduced inUng/ FD, which
also displayed increased anxiety and despair-related behavior.
We therefore speculate that the distinct behavioral phenotype of
Ung/ folate-deficient animals is associated with pyramidal
cell loss and reduced hippocampal BDNF, lending further sup-
port for a role of BDNF in regulating aspects of affective behavior
(Schinder and Poo, 2000; Nestler et al., 2002; Lang et al., 2004;
Ridder et al., 2005). Interestingly, Ung/ mice on the control
diet also showed a mild tendency toward anxiousness and
despair-like reactions.
Spatial learning in the hippocampus-dependent Morris water
maze was predominantly affected by folate deficiency. Several
mechanisms, including neurodegeneration and disturbed neuro-
trophin and neurotransmitter signaling,may have contributed to
this effect. Some previous studies have also described an associa-
tion between acquisition in the place task and levels of neurogen-
esis, especially in old age (Kempermann andGage, 2002;Drapeau
et al., 2003; Wolf et al., 2006). Results reported here fit well with
these earlier reports. However, other studies disrupting neuro-
genesis (Shors et al., 2002; Saxe et al., 2006) failed to demonstrate
an effect on Morris water maze performance. The trend toward
poorer performance ofUng/ FD (place task, target preference
in the probe trial) did not reach statistical significance, possibly
because of sample size.
In summary, our study provides new insight into how folate
deficiency impacts brain function. Folate deficiency leads to in-
creased homocysteine, alters brain monoamine levels, and
strongly impairs hippocampal neurogenesis. Whereas these ef-
fects of low folate are largely compensated for in wild-type ani-
mals, in animals with defective uracil excision repair, along with
changes in BDNF, GSH, and selective neurodegeneration, anx-
ious and despair-like behaviors develop.
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